cagrisema semaglutide cagrilintide phase 3 results 2024 2025 Novo's disappoint analysts, sending stock tumbling - MM+M Novo Nordisk's CagriSema outperforms Ozempic
Description
On platforms like TikTok and Instagram, influencers have been paid to promote GLP-1 patches, sometimes holding an Ozempic pen alongside the patch to visually suggest the two products are equivalent
However, it's crucial to understand the associated risks
2021;9(2):e17573
Compounded tirzepatide is fundamentally different
01022-6/asset/a38873d9-5999-4e60-a3fc-c2fd1cbeca3d/main.assets/gr2_lrg.jpg)
Some patients respond better to one medication than the other depending on tolerance and metabolic response
"This is an update after I went to them for weight loss
